Thymosin fraction 5 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-11-24. Anything still debated is marked as such rather than presented as settled.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
==== Omnipod 5 ==== The Omnipod 5, manufactured by Insulet, is a tubeless insulin pump system that can be integrated with the Dexcom G6 and G7 systems to provide automated glucose control. The system was released in the US in June 2024. Users can control the system through the Omnipod 5 Controller or a compatible Android smartphone. Omnipod 5 App for iPhone is expected to be released in the first half of 2025. The system allows for a simplified pairing process through a QR code scan and features a shortened 30-minute CGM warm-up period, compared to the Dexcom G6, enabling more time spent in Automated Mode. The system uses real-time glucose data to adjust insulin delivery.
=== Viral inhibitors === Influenza viruses are mainly spread from person to person through airborne droplets produced while coughing or sneezing. However, the viruses can also be transmitted when a person touches respiratory droplets settled on an object or surface. It is during this stage that an antiviral surface could play the biggest role in cutting down on the spread of a virus. Glass slides painted with the hydrophobic long-chained polycation N,N dodecyl,methyl-polyethylenimine (N,N-dodecyl,methyl-PEI) are highly lethal to waterborne influenza A viruses, including not only wild-type human and avian strains but also their neuraminidase mutants resistant to anti-influenza drugs. Copper alloy surfaces have been investigated for their antiviral efficacies. After incubation for one hour on copper, active influenza A virus particles were reduced by 75%. After six hours, the particles were reduced on copper by 99.999%. Also, 75% of Adenovirus particles were inactivated on copper (C11000) within 1 hour. Within six hours, 99.999% of the adenovirus particles were inactivated.
On 26 March 2015, Saudi Arabia and several other countries announced that they had begun military operations in Yemen against Houthi rebels. Bahrain, Kuwait, Qatar and the United Arab Emirates issued a statement along with Saudi Arabia saying their goal is to "repel Houthi aggression" in Yemen. Egypt, Jordan, Morocco, and Sudan are also members of the coalition. In addition to airstrikes against targets throughout Yemen, which the General People's Congress blamed for causing dozens of civilian casualties, Egyptian warships reportedly shelled a Houthi column as it advanced toward Aden on 30 March, and Saudi and Houthi forces traded artillery and rocket fire across the border between Saudi Arabia and Yemen. The 8 October 2016 attack by the Saudi Arabian-led coalition killed at least 140 people and injured more than 600 in Sanaa. This was one of the single worst death tolls in the two-year war. Saudi Arabia and its allies accepted the internal review's finding, by the Joint Incidents Assessment Team (JIAT), that the coalition's bombardment of this funeral ceremony was based on faulty information, i.e., that this was a gathering of armed Houthi leaders.
Galactose oxidase is a type II copper protein. It contains a single copper center that adopts square planar or square-based pyramidal coordination geometry. The copper center has five coordinating ligands: two tyrosines (Tyr272 and Tyr495), two histidines (His496 and His581), and a solvent molecule that is usually water. The copper in the active site of galactose oxidase is described as having a "distorted square pyramidal" coordination geometry. Tyr495 is the axial ligand, the other four ligands lie roughly in a plane. Both histidines coordinate with copper through 3-nitrogen. Copper-H2O bond is the longest coordinate bond; it is labile and can be replaced by a substrate molecule. Tyr272 forms a dimer with a cysteine (Cys228) through an ortho carbon of tyrosine and the sulfur atom of cysteine, which is supported by X-ray crystallography studies. The Tyr-Cys cross-link decreases the structural flexibility of Tyr272. This cross-linked tyrosinate is also a free radical. In the fully oxidized form of galactose oxidase, the free radical couples to the copper(II) center antiferromagnetically, supported by EPR spectroscopic studies. Moreover, the formation of cross-linking thioether bond is believed to lower the oxidation potential of Tyr272 phenoxide, making this phenoxyl more easily oxidized to form the radical in post-translational modification. The free radical in galactose oxidase is unusually stable compared to many other protein free radicals. The free radical ligand is stabilized mainly in two ways.
Bacterial infections such as mycoplasma, Legionnaires' disease, syphilis, listeriosis, or E. coli. Viral infections such Epstein-Barr virus, cytomegalovirus, mumps, varicella, rubella, adenovirus, HIV, influenza, or hepatitis C. Parasitic infections such as malaria or trypanosomiasis. Other autoimmune diseases such as systemic lupus erythematosus. Certain types of cancers such as lymphoma, chronic lymphocytic leukemia, Waldenström macroglobulinemia, multiple myeloma, and Kaposi sarcoma. In children, cold agglutinin disease is often secondary to an infection, such as Mycoplasma pneumonia, mononucleosis, and HIV.
Sources: en.wikipedia.org
An over-active renin-angiotensin system leads to vasoconstriction and retention of sodium and water. These effects lead to hypertension. Therefore, renin inhibitors can be used for the treatment of hypertension. This is measured by the plasma renin activity (PRA). In current medical practice, the renin–angiotensin–aldosterone system's overactivity (and resultant hypertension) is more commonly reduced using either ACE inhibitors (such as ramipril and perindopril) or angiotensin II receptor blockers (ARBs, such as losartan, irbesartan or candesartan) rather than a direct oral renin inhibitor. ACE inhibitors or ARBs are also part of the standard treatment after a heart attack. The differential diagnosis of kidney cancer in a young patient with hypertension includes juxtaglomerular cell tumor (reninoma), Wilms' tumor, and renal cell carcinoma, all of which may produce renin.
The spray is a combination of local anaesthetics lidocaine and prilocaine in a metered-dose aerosol that is sprayed directly on the penis to numb sensations. It was developed by the same group that invented the erectile dysfunction drug sildenafil. The drug was approved in Europe and was released in the UK market in November 2016 and within the EU will be marketed by, early in 2017 In the United States, the Food and Drug Administration (FDA) is expected to approve the drug in 2018.
Aquino was assassinated at Manila International Airport (now Ninoy Aquino International Airport). September 1: Civilian Korean Air Lines Flight 007, with 269 passengers, including U.S. Congressman Larry McDonald, is shot down by Soviet interceptor aircraft. September 26: The 1983 Soviet nuclear false alarm incident occurs. The U.S.S.R. nuclear early warning system reports launch of multiple U.S. intercontinental ballistic missiles. Stanislav Yevgrafovich Petrov, an officer of the Soviet Air Defence Forces, correctly identifies them as false alarms. This decision is seen as having prevented a retaliatory nuclear attack based on erroneous data on the United States and its NATO allies, which likely would have resulted in nuclear war and the deaths of hundreds of millions of people. October 25: U.S. forces invade the Caribbean island of Grenada in an attempt to overthrow the Communist government, expel Cuban troops, and abort the construction of a Soviet-funded airstrip. November 2: Exercise Able Archer 83 – Soviet anti-aircraft misinterpret a test of NATO's nuclear warfare procedures as a fake cover for an actual NATO attack; in response, Soviet nuclear forces are put on high alert. December 10: The National Reorganization Process military junta of Argentina is dissolved by democratically elected president Raúl Alfonsín.
reacts with acids, releasing carbonic acid which quickly disintegrates into carbon dioxide and water: CaCO3(s) + 2 H+(aq) → Ca2+(aq) + CO2(g) + H2O(l) releases carbon dioxide upon heating, called a thermal decomposition reaction, or calcination (to above 840 °C in the case of CaCO3), to form calcium oxide, CaO, commonly called quicklime, with reaction enthalpy 178 kJ/mol: CaCO3(s) → CaO(s) + CO2(g) reacts with gaseous hydrogen to form methane and water vapor plus solid calcium oxide or calcium hydroxide depending on temperature and product gas composition. Various metals including palladium and nickel are catalysts for the reaction. Calcium carbonate reacts with water that is saturated with carbon dioxide to form the soluble calcium bicarbonate.
Sources: en.wikipedia.org
== Selective ligands == Numerous selective inhibitors of SIRT2 are known as they have antiviral effects and potential application in cancer treatment, though none of them has been conclusively shown to be highly selective for SIRT2 over all other SIRT subtypes. No highly selective activators of SIRT2 are known at present with non selective activators such as nicotinamide riboside mainly used for research.
=== Backwashing === In backwashing, the transmembrane pressure is periodically inverted by the use of a secondary pump, so that permeate flows back into the feed, lifting the fouling layer from the surface of the membrane. Backwashing is not applicable to spirally wound membranes and is not a general practice in most applications. (See Clean-in-place)
Most classical force fields implicitly include the effect of polarizability, e.g., by scaling up the partial charges obtained from quantum chemical calculations. These partial charges are stationary with respect to the mass of the atom. But molecular dynamics simulations can explicitly model polarizability with the introduction of induced dipoles through different methods, such as Drude particles or fluctuating charges. This allows for a dynamic redistribution of charge between atoms which responds to the local chemical environment. For many years, polarizable MD simulations have been touted as the next generation. For homogenous liquids such as water, increased accuracy has been achieved through the inclusion of polarizability. Some promising results have also been achieved for proteins. However, it is still uncertain how to best approximate polarizability in a simulation. The point becomes more important when a particle experiences different environments during its simulation trajectory, e.g. translocation of a drug through a cell membrane.
The FR Yugoslavia had more demographic variety than most other European countries. According to the 1992 census, the Federal Republic had 10,394,026 inhabitants. The three largest named nationalities were Serbs (6,504,048 inhabitants, or 62.6%), Albanians (1,714,768 inhabitants, or 16.5%), and Montenegrins (519,766 inhabitants, or 5%). The country also had significant populations of Hungarians, ethnic Yugoslavs, ethnic Muslims, Romani, Croats, Bulgarians, Macedonians, Romanians and Vlachs, and others (under 1%). Most of the ethnic diversity was situated in the autonomous provinces of Kosovo and Vojvodina, where smaller numbers of other minority groups could be found. The large Albanian population was chiefly concentrated in Kosovo, with smaller populations in the Preševo Valley, and in the Ulcinj municipality in Montenegro. The Muslim (Slavic Muslims, including Bosniaks and Gorani) population lived mostly in the federal border region (mainly Novi Pazar in Serbia, and Rožaje in Montenegro). The Montenegrin population at the time often considered themselves to be Serbs.
Glutathione peroxidase 6 (GPx-6) is an enzyme that in humans is encoded by the GPX6 gene. This gene product belongs to the glutathione peroxidase family, which functions in the detoxification of hydrogen peroxide. It contains a selenocysteine (Sec) residue at its active site. The selenocysteine is encoded by the UGA codon, which normally signals translation termination. The 3' UTR of Sec-containing genes have a common stem-loop structure, the sec insertion sequence (SECIS), which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Expression of this gene is restricted to embryos and adult olfactory epithelium.
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.